Papers Content and quality of 2000 controlled trials in schizophrenia over 50 years BMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7167.1181 (Published 31 October 1998) Cite this as: BMJ 1998;317:1181 Article Related content Metrics Responses Peer review Related articles Editor's Choice Fifty years of randomised controlled trials Published: 31 October 1998; BMJ 317 doi:10.1136/bmj.317.7167.0 This Week In The BMJ Two thousand schizophrenia trials, 1948-97—and still much room for improvement Published: 31 October 1998; BMJ 317 doi:10.1136/bmj.317.7167.0c Research Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study Published: 27 July 2006; BMJ 333 doi:10.1136/bmj.38881.382755.2F RESEARCH Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study Published: 06 July 2006; BMJ doi:10.1136/bmj.38881.382755.2F Feature How can we regulate medicines better? Published: 18 October 2007; BMJ 335 doi:10.1136/bmj.39281.615706.94 Research Methods & Reporting CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials Published: 24 March 2010; BMJ 340 doi:10.1136/bmj.c869 Letter Trial protocols: time for more than tinkering Published: 17 February 2005; BMJ 330 doi:10.1136/bmj.330.7488.421-b Letter Practical problems in recruiting patients with schizophrenia into randomised controlled trials Published: 17 April 1999; BMJ 318 doi:10.1136/bmj.318.7190.1075 See more Maternal deaths from suicide must be tackled, say experts BMJ December 07, 2016, 355 i6585; DOI: https://doi.org/10.1136/bmj.i6585 Manufacturers tell FDA why they should be able to promote drugs and devices off label BMJ November 14, 2016, 355 i6098; DOI: https://doi.org/10.1136/bmj.i6098 Dietitians have important role in mental health team, say researchers BMJ November 03, 2016, 355 i5913; DOI: https://doi.org/10.1136/bmj.i5913 Spice and all things nasty: the challenge of synthetic cannabinoids BMJ October 24, 2016, 355 i5639; DOI: https://doi.org/10.1136/bmj.i5639 Poorest urban areas face highest rates of psychosis, study finds BMJ October 24, 2016, 355 i5707; DOI: https://doi.org/10.1136/bmj.i5707
